rs1085307563
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_022166.4(XYLT1):c.1730_1733dupATGA(p.Asp578GlufsTer2) variant causes a frameshift, stop gained change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. D578D) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_022166.4 frameshift, stop_gained
Scores
Clinical Significance
Conservation
Publications
- Desbuquois dysplasia 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Desbuquois dysplasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- XYLT1-congenital disorder of glycosylationInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022166.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| XYLT1 | TSL:1 MANE Select | c.1730_1733dupATGA | p.Asp578GlufsTer2 | frameshift stop_gained | Exon 8 of 12 | ENSP00000261381.6 | Q86Y38 | ||
| XYLT1 | c.1730_1733dupATGA | p.Asp578GlufsTer2 | frameshift stop_gained | Exon 8 of 12 | ENSP00000603816.1 | ||||
| ENSG00000261448 | TSL:3 | n.678_681dupCATT | non_coding_transcript_exon | Exon 5 of 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at